A comprehensive view of Biopharmaceuticals / Biologics. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Bioeconomy Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

HCA Healthcare's Sarah Cannon Cancer Institute transitions majority of CAR T-cell therapy patients to outpatient setting, saving over 1,200 hospital bed days and boosting patient satisfaction; move set to meet increasing demand for cell therapies

Core Diagnostics research highlights role of circulating biomarkers in diagnosing and managing immune checkpoint inhibitor-related myocarditis; findings suggests integrating CV biomarkers into oncology trials for improved early recognition and treatment

AstraZeneca completes acquisition of Gracell Biotechnologies, bolstering its pipeline of cell therapies designed to combat cancer and autoimmune diseases; the deal is worth approximately US$1.2B

Immunocore announces clinical trial collaboration and supply agreement with Bristol Myers Squibb to evaluate IMC-F106C PRAME HLA-A02 in combination with nivolumab in its registrational Phase 3 first-line advanced cutaneous melanoma trial

Bristol-Myers Squibb Co. Amplifies Biopharmaceutical R&D Efforts with 50+ Molecules in Development, Champions Immunotherapy Education and Advocates for Heart Health

Ask us about our Bioeconomy market view

Trending Chart

Interactive chart with headline count